FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313887581> ?p ?o ?g. }

• W4313887581 endingPage "254.e9" @default.
• W4313887581 startingPage "254.e1" @default.
• W4313887581 abstract "Toxicities after chimeric antigen receptor T cell (CAR-T) therapy are well known, yet the patient experience during and after CAR-T therapy has not been well described outside of the trial setting. We explored the patient experience after CAR-T therapy to inform the patient-reported outcomes (PRO) measurement approach for the Center for International Blood and Marrow Transplant Research (CIBMTR). We recruited (1) adult patients diagnosed with a hematologic malignancy 14 days to 6 months after receiving a commercial CAR T cell product who had agreed to be contacted by the CIBMTR, (2) caregivers of those patients, and (3) clinical experts in CAR-T therapy. Telephone interviews were conducted following a semistructured guide that included open-ended questions about symptoms and functioning. We conducted a systematic content analysis of each transcript using prespecified codes representing common domains of health, as well as open coding for emergent themes. Forty patients at 29 centers, 15 of their caregivers, and 15 experts from 9 centers participated, representing diversity with respect to age, sex, race/ethnicity, and years in practice (experts). Patients, caregivers, and experts shared largely consistent impressions of the patient experience after CAR-T therapy. Commonly described themes included anxiety, cognitive dysfunction, depression, fatigue, pain, impaired physical function, gastrointestinal symptoms, sexual dysfunction, sleep difficulties, need for support, financial impact, hospitalization, communication with healthcare providers, and the COVID-19 pandemic. Limitations in patients' ability to participate in social roles and activities was the most prevalent theme, found in nearly all interviews. In the setting of CAR-T therapy, a multidimensional approach to PRO measurement is needed that includes physical, mental, and social health, as well as the financial impact of this novel treatment. High-quality existing PRO tools are available to measure these concepts. Results will inform the CIBMTR measurement of PROs after CAR-T therapy and may be applicable to other CAR-T studies that aim to represent patient experiences." @default.
• W4313887581 created "2023-01-10" @default.
• W4313887581 creator A5008386945 @default.
• W4313887581 creator A5013614475 @default.
• W4313887581 creator A5032478325 @default.
• W4313887581 creator A5039314163 @default.
• W4313887581 creator A5039399741 @default.
• W4313887581 creator A5041751558 @default.
• W4313887581 creator A5041841214 @default.
• W4313887581 creator A5086815330 @default.
• W4313887581 date "2023-04-01" @default.
• W4313887581 modified "2023-10-05" @default.
• W4313887581 title "Multi-Stakeholder Qualitative Interviews to Inform Measurement of Patient Reported Outcomes After CAR-T" @default.
• W4313887581 cites W2007010480 @default.
• W4313887581 cites W2016874080 @default.
• W4313887581 cites W2043517828 @default.
• W4313887581 cites W2049863008 @default.
• W4313887581 cites W2121051049 @default.
• W4313887581 cites W2130986983 @default.
• W4313887581 cites W2142225512 @default.
• W4313887581 cites W2142507445 @default.
• W4313887581 cites W2162420979 @default.
• W4313887581 cites W2165452399 @default.
• W4313887581 cites W2346452752 @default.
• W4313887581 cites W2529430742 @default.
• W4313887581 cites W2773804840 @default.
• W4313887581 cites W2787301955 @default.
• W4313887581 cites W2790424199 @default.
• W4313887581 cites W2793320726 @default.
• W4313887581 cites W2899385155 @default.
• W4313887581 cites W2902598369 @default.
• W4313887581 cites W2903062212 @default.
• W4313887581 cites W2911213067 @default.
• W4313887581 cites W2944972326 @default.
• W4313887581 cites W2972114996 @default.
• W4313887581 cites W3101236020 @default.
• W4313887581 cites W3108797206 @default.
• W4313887581 cites W3206710308 @default.
• W4313887581 cites W3209704549 @default.
• W4313887581 cites W3213961466 @default.
• W4313887581 cites W4310296350 @default.
• W4313887581 doi "https://doi.org/10.1016/j.jtct.2023.01.004" @default.
• W4313887581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36634738" @default.
• W4313887581 hasPublicationYear "2023" @default.
• W4313887581 type Work @default.
• W4313887581 citedByCount "1" @default.
• W4313887581 crossrefType "journal-article" @default.
• W4313887581 hasAuthorship W4313887581A5008386945 @default.
• W4313887581 hasAuthorship W4313887581A5013614475 @default.
• W4313887581 hasAuthorship W4313887581A5032478325 @default.
• W4313887581 hasAuthorship W4313887581A5039314163 @default.
• W4313887581 hasAuthorship W4313887581A5039399741 @default.
• W4313887581 hasAuthorship W4313887581A5041751558 @default.
• W4313887581 hasAuthorship W4313887581A5041841214 @default.
• W4313887581 hasAuthorship W4313887581A5086815330 @default.
• W4313887581 hasBestOaLocation W43138875811 @default.
• W4313887581 hasConcept C118552586 @default.
• W4313887581 hasConcept C137403100 @default.
• W4313887581 hasConcept C139719470 @default.
• W4313887581 hasConcept C144024400 @default.
• W4313887581 hasConcept C160735492 @default.
• W4313887581 hasConcept C162324750 @default.
• W4313887581 hasConcept C19165224 @default.
• W4313887581 hasConcept C2776867660 @default.
• W4313887581 hasConcept C50522688 @default.
• W4313887581 hasConcept C512399662 @default.
• W4313887581 hasConcept C558461103 @default.
• W4313887581 hasConcept C71924100 @default.
• W4313887581 hasConceptScore W4313887581C118552586 @default.
• W4313887581 hasConceptScore W4313887581C137403100 @default.
• W4313887581 hasConceptScore W4313887581C139719470 @default.
• W4313887581 hasConceptScore W4313887581C144024400 @default.
• W4313887581 hasConceptScore W4313887581C160735492 @default.
• W4313887581 hasConceptScore W4313887581C162324750 @default.
• W4313887581 hasConceptScore W4313887581C19165224 @default.
• W4313887581 hasConceptScore W4313887581C2776867660 @default.
• W4313887581 hasConceptScore W4313887581C50522688 @default.
• W4313887581 hasConceptScore W4313887581C512399662 @default.
• W4313887581 hasConceptScore W4313887581C558461103 @default.
• W4313887581 hasConceptScore W4313887581C71924100 @default.
• W4313887581 hasIssue "4" @default.
• W4313887581 hasLocation W43138875811 @default.
• W4313887581 hasLocation W43138875812 @default.
• W4313887581 hasLocation W43138875813 @default.
• W4313887581 hasOpenAccess W4313887581 @default.
• W4313887581 hasPrimaryLocation W43138875811 @default.
• W4313887581 hasRelatedWork W1779967659 @default.
• W4313887581 hasRelatedWork W2066028548 @default.
• W4313887581 hasRelatedWork W2133154654 @default.
• W4313887581 hasRelatedWork W2361124574 @default.
• W4313887581 hasRelatedWork W2368617500 @default.
• W4313887581 hasRelatedWork W2377986053 @default.
• W4313887581 hasRelatedWork W2378173657 @default.
• W4313887581 hasRelatedWork W2389845461 @default.
• W4313887581 hasRelatedWork W2413806634 @default.
• W4313887581 hasRelatedWork W3215444405 @default.
• W4313887581 hasVolume "29" @default.
• W4313887581 isParatext "false" @default.

• next